Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.

Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy. Cancer Cell. 2017 05 08; 31(5):711-723.e4.

View in: PubMed

subject areas

Animals
Antigens, CD
Basic-Leucine Zipper Transcription Factors
beta Catenin
CD8-Positive T-Lymphocytes
Cell Line, Tumor
Cell Proliferation
Chemokine CXCL10
Chemokine CXCL9
Chemotaxis, Leukocyte
Dendritic Cells
Genotype
Immunologic Memory
Immunotherapy, Adoptive
Integrin alpha Chains
Melanoma
Mice, Knockout
Phenotype
Repressor Proteins
Signal Transduction
Skin Neoplasms
Time Factors
T-Lymphocytes
Tumor Burden
Tumor Escape
Tumor Microenvironment

authors with profiles

Thomas F. Gajewski